TLX 2.50% $17.55 telix pharmaceuticals limited

Ann: Phase II study for indication expansion of TLX250-CDx doses, page-6

  1. 196 Posts.
    lightbulb Created with Sketch. 24
    that's generally right but a single patient is unlikely to have multiple cancer types. It will be one cancer type that has spread to multiple sites
 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.